At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6 enrolled
Drug / intervention
Fastingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance Spectroscopy
In Brief
An observational study evaluating Fasting for Diabetes Complications and Hypoglycemia. Completed, enrolled 6 participants across 1 site.
Detailed Summary
Hypoglycemia-associated autonomic failure (HAAF), a condition commonly developed in diabetic patients, which causes them to have severely low blood sugar levels. This condition makes clinical management of blood sugar in diabetic patients very challenging. This research seeks to better understand how diabetic patients develop HAAF, and what can be done to prevent it.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Complications, Hypoglycemia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartFeb 2016
First PostedFeb 2016
Primary CompletionMar 2017
Study CompletionJul 2017
TodayJul 2026
First PostedFeb 24, 2016
Enrollment StartFeb 1, 2016
Primary CompletionMar 27, 2017
Study CompletionJul 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 10.4 years ago
Interventions
Fastingbehavioral
72 hour fasting